Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

The investment will be used to advance Nemaura’s R&D programs, which include liquid vaccines that have been reformulated for administration through the skin using its micropatch drug delivery technology.

Nemaura Pharma Receives Funding to Develop Biologic Micropatch System

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

According to results from the FOURIER trial, Repatha significantly reduced the risk of cardiovascular events and death in patients with atherosclerotic cardiovascular disease.

Amgen's PCSK9 mAb Shown to Protect Against Heart Attack and Stroke

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Pump systems must be designed to meet the needs of specific processes, including preventing cross-contamination and damage due to shear forces.

Pumping Fluids in Biopharmaceutical Processing

Susan J. Schniepp is a fellow at Regulatory Compliance Associates, Inc. and a member of Pharmaceutical Technology's Editorial Advisory Board.

Susan Schniepp, distinguished fellow at Regulatory Compliance Associates, 
discusses how to ensure sterility when manufacturing small-scale parenteral batches.

Ensuring Sterility in Small-Scale Production

Pramote Cholayudth previously was the managing director of the Professional Conference Center, Ltd. He currently is a validation consultant to Biolab Co., Ltd., in Thailand. He is the founder and manager of PM consult, cpramote2000@yahoo.com.

This article introduces the concepts of pooled variance and the central limit theorem, which are intended for establishing acceptance criteria for blend uniformity data of granular powder blends when a significant degree of sampling bias is involved.

Establishing Blend Uniformity Acceptance Criteria for Oral Solid-Dosage Forms

Alexandre Juillerat, PhD, innovation senior scientist at Cellectis, discusses novel construct UCART123, an investigational agent that is on deck to be the first gene-edited T-cell product in the United States.

Honing in on the Tumor Microenvironment

The agency recommended approval of a total of eight drugs at its January 2017 meeting, two of which are biosimilars.

EMA Recommends Approval of Two Biosimilars

ADMA will acquire BPC’s plasma-based fractionation and purification plant in Boca Raton, FL and plans to resolve issues at the facility noted in an FDA warning letter.

ADMA Biologics to Acquire Plasma-Based Biologics Facility from Biotest

SGS invested in test equipment for analyzing extractables and leachables at its New Jersey laboratory.

SGS Expands Extractables and Leachables Testing

Vetter expanded visual inspection facilities and controlled-temperature storage at its Ravensburg Vetter West facility in Germany.